Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionWhitener Capital Management, Inc.
Latest Disclosed Ownership7,873 shares
Latest Disclosed Value $ 630,470
Whitener Capital Management, Inc. reports 5.69% decrease in ownership of EW / Edwards Lifesciences Corporation

On April 16, 2026 - Whitener Capital Management, Inc. filed a 13F-HR form disclosing ownership of 7,873 shares of Edwards Lifesciences Corporation (MX:EW) valued at $630,470 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 8,348 shares of Edwards Lifesciences Corporation. This represents a change in shares of -5.69% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 7,873 -475 -5.69 630 -11.39 0.1438
2026-01-23 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 8,348 -1,075 -11.41 712 -2.87 0.1619
2025-10-15 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 9,423 75 0.80 733 0.14 0.1754
2025-07-14 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 9,348 -125 -1.32 731 6.56 0.1936
2025-05-01 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 9,473 -225 -2.32 687 -4.32 0.1943
2025-01-15 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 9,698 -725 -6.96 718 4.37 0.2011
2024-10-29 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 10,423 -2,325 -18.24 688 -41.63 0.1951
2024-07-17 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 12,748 -175 -1.35 1,178 -4.62 0.3566
2024-04-16 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 12,923 -267 -2.02 1,235 22.79 0.4042
2024-01-10 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 13,190 -1,126 -7.87 1,006 1.41 0.3639
2023-11-02 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 14,316 -510 -3.44 992 -29.11 0.3972
2023-07-13 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 14,826 -410 -2.69 1,399 10.95 0.5364
2023-04-12 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 15,236 -2,393 -13.57 1,260 -4.18 0.5268
2023-03-01 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 17,629 -200 -1.12 1,315 -10.73 0.5745
2022-10-28 2022-09-30 13F Edwards Lifesciences COM 28176E108 17,829 -947 -5.04 1,473 -17.48 0.6964
2022-08-09 2022-06-30 13F Edwards Lifesciences COM 28176E108 18,776 -200 -1.05 1,785 -20.06 0.8046
2022-05-11 2022-03-31 13F Edwards Lifesciences COM 28176E108 18,976 -895 -4.50 2,233 -13.25 0.8387
2022-02-14 2021-12-31 13F/A-1 Edwards Lifesciences COM 28176E108 19,871 -394 -1.94 2,574 39.29 0.9201
2021-11-12 2021-09-30 13F Edwards Lifesciences COM 28176E108 20,265 150 0.75 1,848 -11.28 0.8503
2021-08-12 2021-06-30 13F Edwards Lifesciences COM 28176E108 20,115 -125 -0.62 2,083 23.11 0.8294
2021-05-11 2021-03-31 13F Edwards Lifesciences COM 28176E108 20,240 -25 -0.12 1,692 -8.44 0.7334
2021-02-08 2020-12-31 13F Edwards Lifesciences COM 28176E108 20,265 -3,895 -16.12 1,848 -4.15 0.8458
2020-10-09 2020-09-30 13F Edwards Lifesciences COM 28176E108 24,160 -1,070 -4.24 1,928 10.61 0.9286
2020-07-17 2020-06-30 13F Edwards Lifesciences COM 28176E108 25,230 16,920 203.61 1,743 11.23 0.9070
2020-04-24 2020-03-31 13F Edwards Lifesciences COM 28176E108 8,310 75 0.91 1,567 -18.43 1.0134
2020-02-12 2019-12-31 13F Edwards Lifesciences COM 28176E108 8,235 565 7.37 1,921 13.94 0.9961
2019-11-07 2019-09-30 13F Edwards Lifesciences COM 28176E108 7,670 -10 -0.13 1,686 18.90 0.9252
2019-08-02 2019-06-30 13F Edwards Lifesciences COM 28176E108 7,680 940 13.95 1,418 10.01 0.8067
2019-05-02 2019-03-31 13F Edwards Lifesciences COM 28176E108 6,740 -1,100 -14.03 1,289 7.42 0.8432
2019-02-05 2018-12-31 13F Edwards Lifesciences COM 28176E108 7,840 1,550 24.64 1,200 9.59 0.8837
2018-11-07 2018-09-30 13F Edwards Lifesciences COM 28176E108 6,290 -65 -1.02 1,095 18.38 0.7185
2018-08-08 2018-06-30 13F Edwards Lifesciences COM 28176E108 6,355 -50 -0.78 925 3.58 0.7264
2018-04-23 2018-03-31 13F Edwards Lifesciences COM 28176E108 6,405 25 0.39 893 24.20 0.6830
2018-04-23 2017-12-31 13F EDWARDS LIFESCIENCES CORP COM COM 28176E108 6,380 6,380 719 0.6183
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.